Prinomastat hydrochloride
SIGMA/PZ0198 - ≥95% (HPLC)
Synonym: (S)
CAS Number: 192329-42-3 (free base)
Empirical Formula (Hill Notation): C18H21N3O5S2 · HCl
Molecular Weight: 459.97
Linear Formula: C18H21N3O5S2 · HCl
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C18H21N3O5S2.ClH/c1-18 |
| InChI key | UQGWXXLNXBRNBU-NTISSMGPSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.CC1(C)SCCN([C@H]1C(=O) |
| solubility | H2O: 15 mg/mL (clear solution) |
| storage condition | desiccated |
| storage temp. | room temp |
| Application: | Prinomastat hydrochloride has been used as an antagonist for metalloproteinases (MMPs) in Crotalus atrox venom samples and mouse embryo cultures. It may be used as a MMP-2 inhibitor in HepG2 cells. |
| Biochem/physiol Actions: | Prinomastat is a matrix metalloprotease (MMP) inhibitor with selectivity for MMPs 2, 3, 9, 13, and 14. Inhibition of these MMPs has been postulated to block tumor invasion and metastasis. It is extremely potent at MMP-3 and MMP-2 with IC50s, 30 pM & 50 pM, respectively. |
| Biochem/physiol Actions: | Prinomastat is a matrix metalloprotease (MMP) inhibitor. |
| General description: | Prinomastat comprises hydroxamic acid group and chelates with zinc ion. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360 |
| Precautionary statements | P201 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 60-61 |
| Safety Statements | 53-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


